MicroRNA-382 Inhibits Cell Growth and Migration in Colorectal Cancer by Targeting SP1

Yupeng Ren,Hao Zhang,Peng Jiang
DOI: https://doi.org/10.1186/s40659-018-0200-9
2018-01-01
Biological Research
Abstract:Background Emerging evidence showed that microRNAs ( miRs ) play critical roles in human cancers by functioning as either tumor suppressor or oncogene. MIR - 382 was found to function as tumor suppressor in certain cancers. However, the role of MIR - 382 in colorectal cancer (CRC) is largely unknown. Specificity protein 1 (SP1) is highly expressed in several cancers including CRC and is correlated with poor prognosis, but it is unclear whether or not MIR - 382 can regulate the expression of SP1. Methods MIR - 382 expression level was measured by reverse transcription-quantitative polymerase chain reaction. The connection between MIR - 382 and SP1 was validated by luciferase activity reporter assay and western blot assay. Cell counting kit-8 assay and wound-healing assay were conducted to investigate the biological functions of MIR - 382 in CRC. Results In this study, we found MIR - 382 expression was downregulated in CRC tissues and cell lines, and the transfection of MIR - 382 mimic decreased cell growth and migration. Furthermore, we identified SP1 was a direct target of MIR - 382 . Overexpression of MIR - 382 decreased the expression of SP1, whereas MIR - 382 knockdown promoted SP1 expression. We also observed an inversely correlation between MIR - 382 and SP1 in CRC tissues. Additionally, we showed that knockdown of SP1 inhibited cell growth and migration and attenuated the effect of MIR - 382 inhibitor on cell behaviors. Conclusions In conclusion, the present study describes a potential mechanism underlying a MIR - 382 /SP1 link contributing to CRC development. Thus, MIR - 382 may be able to be developed as a novel treatment target for CRC.
What problem does this paper attempt to address?